Scenarios that move ATYR

aTyr Pharma, Inc. - Common Stock

Scenarios that move ATYR: 2 analyses, 0 positive, 2 negative.

  1. · Syndax stock falls 16% as Phase II fibrosis study misses primary goal — ▼ · impact -20 · confidence low · horizon immediate
  2. · Satellos wins FDA IND clearance for Forazapadin in FSHD — ▼ · impact -35 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing